autism spectrum disorder

Korean chipmakers Samsung strives to prevent musculoskeletal disorders in the workplace

Samsung Electronics Co., the world’s largest memory chipmaker, is striving to prevent musculoskeletal disorders (MSDs) in its workplace to imp...

Tech, Media & Telecom Rakuten backs S.Korea’s new mobile carrier Stage X

South Korea’s fledgling mobile carrier Stage X Co. has teamed up with relatively new Japanese mobile company Rakuten Group to crack Korea&rsqu...

Tech, Media & Telecom Korea’s 6G frequency bands picked as standard candidates

Sixth-generation (6G) communication frequency bands proposed by South Korea have been adopted as global standard candidates by the industry's freq...

Tech, Media & Telecom Qualcomm, Samsung execute tech to improve 5G performance

Qualcomm Inc., the leading global mobile chip maker, and Samsung Electronics Co., the world’s second-largest smartphone manufacturer, have suc...

Bio & Pharma Handok to import treatment for rare autoimmune disorder

South Korean pharmaceutical company Handok Inc. on Wednesday said it signed a deal with Dutch immunology specialist Argenx to sell the latter's Vyvg...

Artificial intelligence SK Telecom, SNU Hospital to develop AI diagnosis tool for autism

South Korea's top mobile carrier SK Telecom Co. and Seoul National University Hospital have developed an AI-powered diagnosis tool for the early det...

Bio & Pharma Hanall Biopharma invests in Interon Labs for brain disease treatments

South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...

Bio & Pharma Spectrum to push back launch date of Hanmi-developed drug Poziotinib

Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...

Bio & Pharma Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...

Pharmaceuticals SK Biopharm aims to make it to global top 10 healthcare firms by 2030

South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...